Addex Therapeutics Ltd
SIX:ADXN
Addex Therapeutics Ltd
SIX:ADXN
Price:
0.1155 CHF
0.43%
Market Closed
Updated:
Apr 28, 2024
Addex Therapeutics Ltd
Cash from Investing Activities
|
Addex Therapeutics Ltd
Cash from Investing Activities Peer Comparison
Comparables:
ADCT
CRSP
BSLN
IDIA
KURN
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Addex Therapeutics Ltd
SIX:ADXN
|
Cash from Investing Activities
-CHf5.7k
|
CAGR 3-Years
44%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
ADC Therapeutics SA
NYSE:ADCT
|
Cash from Investing Activities
-$3.2m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Cash from Investing Activities
$374.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Cash from Investing Activities
-CHf1m
|
CAGR 3-Years
69%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
30%
|
|
|
Idorsia Ltd
SIX:IDIA
|
Cash from Investing Activities
CHf743.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Kuros Biosciences AG
SIX:KURN
|
Cash from Investing Activities
-CHf326k
|
CAGR 3-Years
-14%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
See Also
What is Addex Therapeutics Ltd's Cash from Investing Activities?
Cash from Investing Activities
-5.7k
CHF
-5.7k
CHF
Based on the financial report for Sep 30, 2023, Addex Therapeutics Ltd's Cash from Investing Activities amounts to -5.7k CHF.
What is Addex Therapeutics Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 3Y
44%
44%
Over the last year, the Cash from Investing Activities growth was 74%. The average annual Cash from Investing Activities growth rates for Addex Therapeutics Ltd have been 44% over the past three years .
You don't have any saved screeners yet
